Gタンパク質共役受容体の世界市場レポート 2025年

Gタンパク質共役受容体市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR7.0％で44億6,000万米ドルに成長します。予測期間の成長は、個別化医療、希少疾患への注目の高まり、創薬における人工知能、患者中心の医薬品開発、環境・社会的要因、バイオシミラー市場の成長に起因すると考えられます。予測期間における主な動向としては、バイオテクノロジーの進歩、研究開発投資の増加、技術革新、共同研究・提携、デジタル治療薬などが挙げられます。

がんの有病率の増加は、今後数年間におけるGタンパク質共役受容体（GPCR）市場の成長を促進すると予想されます。がんは、異常細胞の無秩序な拡散を特徴とする疾患で、周囲の組織に侵入し、体内のリンパ系や血管系を通じて拡散します。GPCRは、増殖シグナル伝達、複製不死、成長抑制因子の回避、アポトーシスに対する抵抗性、浸潤・転移の活性化など、がん進行の鍵となるプロセスの制御に重要な役割を果たしています。例えば、2023年1月、米国の専門機関である米国がん協会は、2023年に米国で新たに診断されたがん患者は195万8310人で、2022年の推定190万人から増加したと報告しました。このように、がんの有病率の上昇がGタンパク質共役受容体市場の成長を大きく促進しています。

ヘルスケア支出の増加は、Gタンパク質共役受容体（GPCR）市場の成長を促進すると予想されます。ヘルスケア支出は、個人レベル、地域レベル、国家レベル、世界レベルのいずれであっても、特定期間におけるヘルスケア関連のサービス、製品、活動に対する総支出を包含します。ヘルスケア支出の増加は通常、ヘルスケアサービスや施設の拡大につながり、その結果、医療提供者がさまざまな疾患や症状に対する先進的かつ革新的な治療法を求めるようになるため、GPCR標的薬に対する需要が高まることになります。例えば、英国の国家統計機関であるOffice for National Statisticsは、2022年に英国のヘルスケア支出が約3,548億8,000万米ドル（2,830億英ポンド）に達し、2021年と比較して名目で0.7％増加したと報告しています。したがって、ヘルスケア支出の増加は、Gタンパク質共役受容体市場の成長に大きく寄与すると予想されます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界のGタンパク質共役受容体PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のGタンパク質共役受容体市場：成長率分析
• 世界のGタンパク質共役受容体市場の実績：規模と成長, 2019-2024
• 世界のGタンパク質共役受容体市場の予測：規模と成長, 2024-2029, 2034F
• 世界のGタンパク質共役受容体総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のGタンパク質共役受容体市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 細胞株
• 検出キット
• 細胞培養試薬
• リガンド
• 世界のGタンパク質共役受容体市場：分析別、実績と予測, 2019-2024, 2024-2029F, 2034F
• CAMP機能アッセイ
• カルシウム機能アッセイ
• B-アレスチン機能アッセイ
• 放射性リガンド結合およびGTPYS機能アッセイ
• 内在化アッセイ
• 輸送アッセイ
• 世界のGタンパク質共役受容体市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• がん研究
• 中枢神経系研究
• 代謝研究
• 心臓血管研究
• 炎症研究
• 呼吸器研究
• その他の用途
• 世界のGタンパク質共役受容体市場、タイプ別サブセグメンテーション：細胞株、実績と予測, 2019-2024, 2024-2029F, 2034F
• GPCR発現細胞株
• 安定細胞株と一過性細胞株
• 世界のGタンパク質共役受容体市場、タイプ別サブセグメンテーション：検出キット、実績と予測, 2019-2024, 2024-2029F, 2034F
• ELISAキット
• ハイスループットスクリーニングキット
• レポーター遺伝子アッセイ
• 世界のGタンパク質共役受容体市場、タイプ別サブセグメンテーション：細胞培養試薬、実績と予測, 2019-2024, 2024-2029F, 2034F
• メディアとサプリメント
• トランスフェクション試薬
• 成長因子
• 世界のGタンパク質共役受容体市場、タイプ別サブセグメンテーション：リガンド、実績と予測, 2019-2024, 2024-2029F, 2034F
• アゴニスト
• アンタゴニスト
• インバースアゴニスト

第7章 地域別・国別分析

• 世界のGタンパク質共役受容体市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のGタンパク質共役受容体市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• Gタンパク質共役受容体市場：競合情勢
• Gタンパク質共役受容体市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Novartis International AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Sanofi SA
• Bristol-Myers Squibb Company
• AstraZeneca Plc
• GlaxoSmithKline Plc
• Danaher Corporation
• Takeda Pharmaceutical Company Limited
• Eli Lilly and Company
• Merck KGaA
• Boehringer Ingelheim
• Teva Pharmaceutical Industries Ltd.
• Daiichi Sankyo Company Limited
• Thermo Fisher Scientific Inc.
• Perkin Elmer Inc.
• Qiagen N.V.
• Bio-Techne Corporation

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• Gタンパク質共役受容体市場2029：新たな機会を提供する国
• Gタンパク質共役受容体市場2029：新たな機会を提供するセグメント
• Gタンパク質共役受容体市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

G-protein coupled receptors, also known as seven-(pass)-transmembrane receptors, are a type of membrane receptor located in the cell membrane. Their primary function is to bind extracellular chemicals and transmit signals from these substances to intracellular molecules. Representing the largest family of membrane proteins, GPCRs play a pivotal role in mediating cellular responses to hormones and neurotransmitters. They are responsible for functions such as vision, olfaction, and taste.

The main offerings associated with G-protein-coupled receptors include cell lines, detection kits, cell culture reagents, and ligands. A cell line refers to a selected uniform cell culture derived from a population of cells typically sourced from a homogeneous tissue. Various types of assays, including camp functional assays, calcium functional assays, B-arrestin functional assays, radioligand binding and GTPYS functional assays, internalization assays, and trafficking assays, are employed in diverse applications. These applications span areas such as cancer research, CNS research, metabolic research, cardiovascular research, inflammation research, respiratory research, and others.

The G-protein-coupled receptors market research report is one of a series of new reports from The Business Research Company that provides G-protein-coupled receptors market statistics, including the G-protein-coupled receptors industry global market size, regional shares, competitors with a G-protein-coupled receptors market share, detailed G-protein-coupled receptors market segments, G-protein-coupled receptors market trends, and opportunities, and any further data you may need to thrive in the G-protein-coupled receptors industry. This G-protein-coupled receptors market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The G-protein coupled receptors market size has grown strongly in recent years. It will grow from $3.2 billion in 2024 to $3.41 billion in 2025 at a compound annual growth rate (CAGR) of 6.6%. The growth in the historic period can be attributed to drug discovery advances, FDA approvals, genomic discoveries, emerging markets, market consolidation, growing aging population

The G-protein coupled receptors market size is expected to see strong growth in the next few years. It will grow to $4.46 billion in 2029 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to personalized medicine, increased focus on rare diseases, artificial intelligence in drug discovery, patient-centric drug development, environmental and social factors, biosimilar market growth. Major trends in the forecast period include biotechnology advancements, increased r&d investment, technological innovations, collaborations and partnerships, digital therapeutics.

The increasing prevalence of cancer is expected to drive the growth of the G-protein-coupled receptors (GPCRs) market in the coming years. Cancer is a disease characterized by the uncontrolled spread of abnormal cells, which can invade surrounding tissues and disseminate through the body's lymphatic and vascular systems. GPCRs play a crucial role in regulating processes that are key to cancer progression, such as proliferative signaling, replicative immortality, evasion of growth suppressors, resistance to apoptosis, and activation of invasion and metastasis. For example, in January 2023, the American Cancer Society, a US-based professional organization, reported that there were 1,958,310 new cancer cases diagnosed in the United States in 2023, an increase from the estimated 1.9 million new cases in 2022. Thus, the rising prevalence of cancer is significantly driving the growth of the G-protein-coupled receptors market.

Rising healthcare expenditures are expected to drive the growth of the G-protein-coupled receptors (GPCRs) market. Healthcare expenditures encompass the total spending on healthcare-related services, products, and activities over a specific period, whether at the individual, community, national, or global level. Increased healthcare spending typically results in the expansion of healthcare services and facilities, which, in turn, leads to a higher demand for GPCR-targeted drugs as healthcare providers seek advanced and innovative treatments for various diseases and conditions. For instance, in 2022, the Office for National Statistics, a UK-based national statistics organization, reported that UK healthcare expenditure reached approximately $354.88 billion (£283 billion), marking a nominal increase of 0.7% compared to 2021. Therefore, the rise in healthcare expenditures is expected to significantly contribute to the growth of the G-protein-coupled receptors market.

A prominent trend gaining traction in the G-protein-coupled receptor (GPCR) market is the strategic investment to advance GPCR screening and antibody development. Leading companies in the GPCR sector are actively seeking investments to propel the development of drugs and medication technologies associated with GPCR-related diseases. For example, in February 2023, LifeArc Ventures, a venture capital firm based in the UK, invested $16 million in Maxion Therapeutics, a UK-based drug discovery company. This investment aims to advance antibody development for previously untreatable ion channel and GPCR-driven disorders, leveraging the proprietary KnotBody technology for the development of antibody therapeutics targeting ion channels and GPCRs.

Major companies in the G-protein-coupled receptors (GPCRs) market are initiating Initial Public Offerings (IPOs) to enhance their development of drugs targeting GPCRs. This move aims to accelerate research and development, advance clinical trials, and introduce innovative therapies for various diseases, including cancer, neurological disorders, and metabolic conditions. The funds raised from these IPOs will primarily support the development of the companies' lead product candidates aimed at chronic metabolic and pulmonary diseases. In particular, the proceeds are designated for advancing their glucagon-like peptide-1 receptor (GLP-1R) agonist program, which focuses on diabetes and obesity treatments. For example, in February 2023, Structure Therapeutics Inc., a US-based company, successfully completed its IPO, raising $161 million to further its development of GPCR-based therapeutics. The company offered 10,740,000 American depositary shares (ADSs) at $15.00 per ADS, significantly exceeding its initial projections. The shares began trading on the Nasdaq Global Market under the ticker symbol "GPCR."

In December 2023, Danaher Corporation, a US-based company, acquired Abcam Plc for an undisclosed amount. This acquisition is intended to enhance Danaher's portfolio by integrating Abcam's expertise in G-protein-coupled receptors (GPCRs). Abcam Plc is a UK-based company that specializes in the provision of GPCRs.

Major companies operating in the G-protein coupled receptors market include Pfizer Inc., Roche Holding AG, AbbVie Inc., Bayer AG, Novartis International AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca Plc, GlaxoSmithKline Plc, Danaher Corporation, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Merck KGaA, Boehringer Ingelheim, Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Limited, Thermo Fisher Scientific Inc., Perkin Elmer Inc., Qiagen N.V., Bio-Techne Corporation, Abcam PLC, Cara Therapeutics Inc., Sosei Heptares Ltd., Eurofins DiscoverX Corporation, Crinetics Pharmaceuticals Inc., Domain Therapeutics SA, Addex Pharmaceuticals Ltd., Escient Pharmaceuticals Inc., Structure Therapeutics, Septerna

North America was the largest region in the G-protein coupled receptors market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the g-protein coupled receptors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the g-protein coupled receptors market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The G-protein-coupled receptors market consists of revenues earned by entities by providing GPCR screening and profiling services, GPCR antibodies and immunoassays, hormones visual control. The market value includes the value of related goods sold by the service provider or included within the service offering. The G-protein-coupled receptors market also includes sales of adenosine, serotonin, and metabotropic receptor. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

G-Protein Coupled Receptors Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on g-protein coupled receptors market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for g-protein coupled receptors ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The g-protein coupled receptors market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Cell Lines; Detection Kits; Cell Culture Reagents; Ligands
• 2) By Assay: CAMP Functional Assays; Calcium Functional Assays; B-Arrestin Functional Assays; Radioligand Binding And GTPYS Functional Assays; Internalization Assays; Trafficking Assays
• 3) By Applications: Cancer Research; CNS Research; Metabolic Research; Cardiovascular Research; Inflammation Research; Respiratory Research; Other Applications
• Subsegments:
• 1) By Cell Lines: GPCR-Expressing Cell Lines; Stable And Transient Cell Lines
• 2) By Detection Kits: ELISA Kits; High-Throughput Screening Kits; Reporter Gene Assays
• 3) By Cell Culture Reagents: Media And Supplements; Transfection Reagents; Growth Factors
• 4) By Ligands: Agonists; Antagonists; Inverse Agonists
• Companies Mentioned: Pfizer Inc.; Roche Holding AG; AbbVie Inc.; Bayer AG; Novartis International AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. G-Protein Coupled Receptors Market Characteristics

3. G-Protein Coupled Receptors Market Trends And Strategies

4. G-Protein Coupled Receptors Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global G-Protein Coupled Receptors Growth Analysis And Strategic Analysis Framework

• 5.1. Global G-Protein Coupled Receptors PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global G-Protein Coupled Receptors Market Growth Rate Analysis
• 5.4. Global G-Protein Coupled Receptors Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global G-Protein Coupled Receptors Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global G-Protein Coupled Receptors Total Addressable Market (TAM)

6. G-Protein Coupled Receptors Market Segmentation

• 6.1. Global G-Protein Coupled Receptors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cell Lines
• Detection Kits
• Cell Culture Reagents
• Ligands
• 6.2. Global G-Protein Coupled Receptors Market, Segmentation By Assay, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• CAMP Functional Assays
• Calcium Functional Assays
• B-Arrestin Functional Assays
• Radioligand Binding and GTPYS Functional Assays
• Internalization Assays
• Trafficking Assays
• 6.3. Global G-Protein Coupled Receptors Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cancer Research
• CNS Research
• Metabolic Research
• Cardiovascular Research
• Inflammation Research
• Respiratory Research
• Other Applications
• 6.4. Global G-Protein Coupled Receptors Market, Sub-Segmentation Of Cell Lines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• GPCR-Expressing Cell Lines
• Stable And Transient Cell Lines
• 6.5. Global G-Protein Coupled Receptors Market, Sub-Segmentation Of Detection Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• ELISA Kits
• High-Throughput Screening Kits
• Reporter Gene Assays
• 6.6. Global G-Protein Coupled Receptors Market, Sub-Segmentation Of Cell Culture Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Media And Supplements
• Transfection Reagents
• Growth Factors
• 6.7. Global G-Protein Coupled Receptors Market, Sub-Segmentation Of Ligands, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Agonists
• Antagonists
• Inverse Agonists

7. G-Protein Coupled Receptors Market Regional And Country Analysis

• 7.1. Global G-Protein Coupled Receptors Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global G-Protein Coupled Receptors Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific G-Protein Coupled Receptors Market

• 8.1. Asia-Pacific G-Protein Coupled Receptors Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific G-Protein Coupled Receptors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific G-Protein Coupled Receptors Market, Segmentation By Assay, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific G-Protein Coupled Receptors Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China G-Protein Coupled Receptors Market

• 9.1. China G-Protein Coupled Receptors Market Overview
• 9.2. China G-Protein Coupled Receptors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China G-Protein Coupled Receptors Market, Segmentation By Assay, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China G-Protein Coupled Receptors Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India G-Protein Coupled Receptors Market

• 10.1. India G-Protein Coupled Receptors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India G-Protein Coupled Receptors Market, Segmentation By Assay, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India G-Protein Coupled Receptors Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan G-Protein Coupled Receptors Market

• 11.1. Japan G-Protein Coupled Receptors Market Overview
• 11.2. Japan G-Protein Coupled Receptors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan G-Protein Coupled Receptors Market, Segmentation By Assay, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan G-Protein Coupled Receptors Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia G-Protein Coupled Receptors Market

• 12.1. Australia G-Protein Coupled Receptors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia G-Protein Coupled Receptors Market, Segmentation By Assay, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia G-Protein Coupled Receptors Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia G-Protein Coupled Receptors Market

• 13.1. Indonesia G-Protein Coupled Receptors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia G-Protein Coupled Receptors Market, Segmentation By Assay, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia G-Protein Coupled Receptors Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea G-Protein Coupled Receptors Market

• 14.1. South Korea G-Protein Coupled Receptors Market Overview
• 14.2. South Korea G-Protein Coupled Receptors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea G-Protein Coupled Receptors Market, Segmentation By Assay, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea G-Protein Coupled Receptors Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe G-Protein Coupled Receptors Market

• 15.1. Western Europe G-Protein Coupled Receptors Market Overview
• 15.2. Western Europe G-Protein Coupled Receptors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe G-Protein Coupled Receptors Market, Segmentation By Assay, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe G-Protein Coupled Receptors Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK G-Protein Coupled Receptors Market

• 16.1. UK G-Protein Coupled Receptors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK G-Protein Coupled Receptors Market, Segmentation By Assay, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK G-Protein Coupled Receptors Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany G-Protein Coupled Receptors Market

• 17.1. Germany G-Protein Coupled Receptors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany G-Protein Coupled Receptors Market, Segmentation By Assay, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany G-Protein Coupled Receptors Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France G-Protein Coupled Receptors Market

• 18.1. France G-Protein Coupled Receptors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France G-Protein Coupled Receptors Market, Segmentation By Assay, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France G-Protein Coupled Receptors Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy G-Protein Coupled Receptors Market

• 19.1. Italy G-Protein Coupled Receptors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy G-Protein Coupled Receptors Market, Segmentation By Assay, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy G-Protein Coupled Receptors Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain G-Protein Coupled Receptors Market

• 20.1. Spain G-Protein Coupled Receptors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain G-Protein Coupled Receptors Market, Segmentation By Assay, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain G-Protein Coupled Receptors Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe G-Protein Coupled Receptors Market

• 21.1. Eastern Europe G-Protein Coupled Receptors Market Overview
• 21.2. Eastern Europe G-Protein Coupled Receptors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe G-Protein Coupled Receptors Market, Segmentation By Assay, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe G-Protein Coupled Receptors Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia G-Protein Coupled Receptors Market

• 22.1. Russia G-Protein Coupled Receptors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia G-Protein Coupled Receptors Market, Segmentation By Assay, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia G-Protein Coupled Receptors Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America G-Protein Coupled Receptors Market

• 23.1. North America G-Protein Coupled Receptors Market Overview
• 23.2. North America G-Protein Coupled Receptors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America G-Protein Coupled Receptors Market, Segmentation By Assay, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America G-Protein Coupled Receptors Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA G-Protein Coupled Receptors Market

• 24.1. USA G-Protein Coupled Receptors Market Overview
• 24.2. USA G-Protein Coupled Receptors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA G-Protein Coupled Receptors Market, Segmentation By Assay, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA G-Protein Coupled Receptors Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada G-Protein Coupled Receptors Market

• 25.1. Canada G-Protein Coupled Receptors Market Overview
• 25.2. Canada G-Protein Coupled Receptors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada G-Protein Coupled Receptors Market, Segmentation By Assay, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada G-Protein Coupled Receptors Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America G-Protein Coupled Receptors Market

• 26.1. South America G-Protein Coupled Receptors Market Overview
• 26.2. South America G-Protein Coupled Receptors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America G-Protein Coupled Receptors Market, Segmentation By Assay, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America G-Protein Coupled Receptors Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil G-Protein Coupled Receptors Market

• 27.1. Brazil G-Protein Coupled Receptors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil G-Protein Coupled Receptors Market, Segmentation By Assay, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil G-Protein Coupled Receptors Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East G-Protein Coupled Receptors Market

• 28.1. Middle East G-Protein Coupled Receptors Market Overview
• 28.2. Middle East G-Protein Coupled Receptors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East G-Protein Coupled Receptors Market, Segmentation By Assay, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East G-Protein Coupled Receptors Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa G-Protein Coupled Receptors Market

• 29.1. Africa G-Protein Coupled Receptors Market Overview
• 29.2. Africa G-Protein Coupled Receptors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa G-Protein Coupled Receptors Market, Segmentation By Assay, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa G-Protein Coupled Receptors Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. G-Protein Coupled Receptors Market Competitive Landscape And Company Profiles

• 30.1. G-Protein Coupled Receptors Market Competitive Landscape
• 30.2. G-Protein Coupled Receptors Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Novartis International AG Overview, Products and Services, Strategy and Financial Analysis

31. G-Protein Coupled Receptors Market Other Major And Innovative Companies

• 31.1. Sanofi SA
• 31.2. Bristol-Myers Squibb Company
• 31.3. AstraZeneca Plc
• 31.4. GlaxoSmithKline Plc
• 31.5. Danaher Corporation
• 31.6. Takeda Pharmaceutical Company Limited
• 31.7. Eli Lilly and Company
• 31.8. Merck KGaA
• 31.9. Boehringer Ingelheim
• 31.10. Teva Pharmaceutical Industries Ltd.
• 31.11. Daiichi Sankyo Company Limited
• 31.12. Thermo Fisher Scientific Inc.
• 31.13. Perkin Elmer Inc.
• 31.14. Qiagen N.V.
• 31.15. Bio-Techne Corporation

32. Global G-Protein Coupled Receptors Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The G-Protein Coupled Receptors Market

34. Recent Developments In The G-Protein Coupled Receptors Market

35. G-Protein Coupled Receptors Market High Potential Countries, Segments and Strategies

• 35.1 G-Protein Coupled Receptors Market In 2029 - Countries Offering Most New Opportunities
• 35.2 G-Protein Coupled Receptors Market In 2029 - Segments Offering Most New Opportunities
• 35.3 G-Protein Coupled Receptors Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer